You are here: Industry Insights > AAV

News List

Thermo Fisher supports gene developers with new AAV manufacturing solutions cphi-online
July 12, 2021
Thermo Fisher Scientific has expanded its gene therapy portfolio to include a new media panel, gene kit and advanced purification resins to support gene therapy developers seeking to rapidly and efficiently scale adeno-associated viral (AAV) production.
Thermo Fisher Scientific Expands Gene Therapy Portfolio contractpharma
July 08, 2021
Thermo Fisher Scientific has unveiled a new set of solutions to support adeno-associated viral (AAV) manufacturing.
Viralgen opens expanded AAV manufacturing facility in Spain firstwordpharma
July 06, 2021
The CDMO's fivefold capacity increase will provide early preclinical through to commercialisation support
Freeline Announces Executive Leadership Changes firstwordpharma
July 01, 2021
FRLN today announced the expansion of its executive leadership team with the appointment of James "Jay" Bircher as Chief Technical Operations Officer effective July 1, 2021.
Neurophth Therapeutics and Hopstem Biotechnology Announce Strategic Partnership to Develop Human Induced Pluripotent Stem Cell-Derived Therapies for the Treatment of Ocular Diseases prnasia
June 02, 2021
Neurophth Biotechnology Ltd. announced a strategic partnership aiming to provide human iPSC-derived cell therapy for ocular diseases.
Biogen partners with Ginkgo Bioworks on gene therapy manufacturing platform pharmatimes
May 25, 2021
Biogen has entered into a new collaboration with Ginkgo Bioworks to develop a novel gene therapy manufacturing platform to ‘redefine the industry standard’ for manufacturing AAV-based vectors.
MilliporeSigma Announces VectorY as Winner of its Advance Biotech Grant americanpharmaceuticalreview
May 19, 2021
MilliporeSigma announced that VectorY has been selected as the European winner of its 2021 Advance Biotech Grant Program.
Luye Life Sciences Unveils Cutting-edge Advances in Gene and Cell Therapy at ASGCT 2021 prnasia
May 14, 2021
The Boston R&D Center and GeneLeap Biotech, two subsidiaries of Luye Life Sciences Group, took part in the 24th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, presenting the progress of four of the company's latest preclinical ...
Albumedix Extends Research Collaboration with Cobra Biologics contractpharma
May 06, 2021
Albumedix has extended its research collaboration with Cobra Biologics, the gene therapy division of Cognate BioServices, a Charles River Laboratories International company.
Neurophth Announces IND Approval by the NMPA for Leber Hereditary Optic Neuropathy Gene Therapy prnasia
April 02, 2021
Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company developing adeno-associated viral (AAV)-delivered gene therapies for the treatment of ocular diseases, recently announced the Center for Drug Evaluation (CDE) of ...

Previous page 1 2 3 4 Next page